These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 27118127

  • 21. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N, Buffet C, Trésallet C, Tissier F, Leenhardt L, Menegaux F.
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [Abstract] [Full Text] [Related]

  • 22. Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.
    Cho SG, Kwon SY, Kim J, Cho DH, Na MH, Kang SR, Yoo SW, Song HC.
    Medicine (Baltimore); 2019 Apr; 98(16):e14858. PubMed ID: 31008921
    [Abstract] [Full Text] [Related]

  • 23. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB.
    Cancer; 1998 Jan 15; 82(2):375-88. PubMed ID: 9445196
    [Abstract] [Full Text] [Related]

  • 24. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
    Kim MH, Ko SH, Bae JS, Lee SH, Jung CK, Lim DJ, Baek KH, Kim SH, Lee JM, Kang MI, Cha BY.
    Thyroid; 2013 Nov 15; 23(11):1452-60. PubMed ID: 23688271
    [Abstract] [Full Text] [Related]

  • 25. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
    Roh JL, Park JW, Jeong J, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2017 Sep 15; 116(4):450-458. PubMed ID: 28608492
    [Abstract] [Full Text] [Related]

  • 26. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results.
    Mauri G, Cova L, Tondolo T, Ierace T, Baroli A, Di Mauro E, Pacella CM, Goldberg SN, Solbiati L.
    J Clin Endocrinol Metab; 2013 Jul 15; 98(7):E1203-7. PubMed ID: 23666969
    [Abstract] [Full Text] [Related]

  • 27. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E, Thomas S, Dinan MA, Perkins JM, Roman SA, Sosa JA.
    Endocrine; 2016 Jun 15; 52(3):579-86. PubMed ID: 26708045
    [Abstract] [Full Text] [Related]

  • 28. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
    Choi JW, Yoon YH, Yoon YH, Kim SM, Koo BS.
    Ann Surg Oncol; 2011 May 15; 18(5):1306-11. PubMed ID: 21140231
    [Abstract] [Full Text] [Related]

  • 29. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
    Kim H, Na KJ, Choi JH, Ahn BC, Ahn D, Sohn JH.
    Eur Arch Otorhinolaryngol; 2016 Jun 15; 273(6):1569-76. PubMed ID: 25971994
    [Abstract] [Full Text] [Related]

  • 30. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P, Kohlfürst S.
    Semin Nucl Med; 2006 Jul 15; 36(3):194-205. PubMed ID: 16762610
    [Abstract] [Full Text] [Related]

  • 31. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Wu X, Gu H, Gao Y, Li B, Fan R.
    Nucl Med Commun; 2018 Jan 15; 39(1):22-27. PubMed ID: 29135721
    [Abstract] [Full Text] [Related]

  • 32. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
    Sapuppo G, Palermo F, Russo M, Tavarelli M, Masucci R, Squatrito S, Vigneri R, Pellegriti G.
    J Endocrinol Invest; 2017 Dec 15; 40(12):1355-1363. PubMed ID: 28646475
    [Abstract] [Full Text] [Related]

  • 33. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H.
    Cancer; 1996 Jan 01; 77(1):172-80. PubMed ID: 8630926
    [Abstract] [Full Text] [Related]

  • 34. Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
    Hempel JM, Kloeckner R, Krick S, Pinto Dos Santos D, Schadmand-Fischer S, Boeßert P, Bisdas S, Weber MM, Fottner C, Musholt TJ, Schreckenberger M, Miederer M.
    Cancer Imaging; 2016 Nov 03; 16(1):37. PubMed ID: 27809936
    [Abstract] [Full Text] [Related]

  • 35. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
    Liu Y, Xu SY, Liu K, Wang XL, Liu SY, Xu ZG, Liu J.
    Zhonghua Zhong Liu Za Zhi; 2021 Apr 23; 43(4):477-483. PubMed ID: 33902211
    [Abstract] [Full Text] [Related]

  • 36. Treatment of Metastatic Lymph Nodes in the Neck from Papillary Thyroid Carcinoma with Percutaneous Laser Ablation.
    Mauri G, Cova L, Ierace T, Baroli A, Di Mauro E, Pacella CM, Goldberg SN, Solbiati L.
    Cardiovasc Intervent Radiol; 2016 Jul 23; 39(7):1023-30. PubMed ID: 26911732
    [Abstract] [Full Text] [Related]

  • 37. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P, Feng HJ, Ouyang W, Wu JQ, Wang J, Sun YG, Xian JL, Huang LH.
    Endocr Pract; 2016 Sep 23; 22(9):1048-56. PubMed ID: 27124694
    [Abstract] [Full Text] [Related]

  • 38. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
    Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C.
    Clin Nucl Med; 2018 Mar 23; 43(3):162-167. PubMed ID: 29356744
    [Abstract] [Full Text] [Related]

  • 39. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C, Risse JH, Biersack HJ, Bender H.
    Cancer Biother Radiopharm; 2007 Dec 23; 22(6):740-7. PubMed ID: 18158764
    [Abstract] [Full Text] [Related]

  • 40. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG.
    Surgery; 2017 Feb 23; 161(2):465-471. PubMed ID: 27574773
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.